Filmmaker Diagnosed with Lymphoma

Julie Reichert, who along with her partner Steven Bogner, have a hit film at the Sundance Film Festival, had to cut short her plans when tests indicated she has lymphoma.



Bognar and Reichert spent nearly nine years filming five children with cancer at Cincinnati Children's Hospital Medical Center for "A Lion in the House" nominated for best documentary at Sundance. The festival ends Sunday.



More than two dozen people involved with the film - cancer patients' families, their doctors and film editors - flew to Utah, for the premiere last Friday. The film received two standing ovations last weekend. "We couldn't have hoped for a better response," Bognar says. The Salt Lake Tribune called "Lion" as one of the best films at the festival, citing its "courageous, inspiring and heartwarming stories."



While Reichert's diagnosis is ironic given her work filming children with cancer (and a daughter who is a cancer survivor), Bogner says Reichert "... is ready to look at her own cancer."



We wish her well during her treatment. More about the film at ITVS.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap